VOLIBRIS® (ambrisentan)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01406327 (ClinicalTrials.gov)	December 14, 2010	28/7/2011	Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)	Drug Use Investigation for VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)	Hypertension, Pulmonary	Drug: Ambrisentan	GlaxoSmithKline	NULL	Completed	N/A	N/A	All	900		NULL
2	EUCTR2010-021572-29-FR (EUCTR)		11/10/2011	Testing medicines to treat children with pulmonary arterial hypertension (PAH)Testing medicines to t ...	An open-label, long term extension study for treatment of pulmonary arterial hypertension in paediat ...	Pulmonary Arterial Hypertension MedDRA version: 14.0;Level: PT;Classification code 10064911;Term: Pu ...	Trade Name: VOLIBRIS® (ambrisentan) Product Name: ambrisentan Product Code: GSK1325760 INN or Proposed ...	GlaxoSmithKline Research & Development Limited	NULL	Not Recruiting			Female: yes Male: yes	66	Phase 2	United States;France;Hungary;Greece;Spain;Netherlands;Germany;Italy;Japan

First Previous1Next Last